You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Baseline patient characteristics and treatment

From: Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

   Patients (N=204)
Age (y/o) Median 69 (48~90)  
  Age ≤ 60 12.7%
  60 < Age ≤ 70 46.6%
  Age > 70 40.7%
Race White 54.4%
  Black 38.7%
  Other 7.8%
Charlson Comorbidity Index CCI=0 65.2%
  CCI=1 21.1%
  CCI≥2 13.7%
Body Mass Index (BMI) Median 27.60 (15.02-44.96)  
  BMI ≥ 30 30.5%
Partner Status Married or Partnered 76.0%
  Not Partnered 24.0%
Employment Status Working 48.0%
  Not Working 52.0%
Median Prostate Volume (cc) Median 39 (11.6-138.7) cc  
Procedure for BPH   7.8%
α 1A inhibitor usage   27.9%
Risk Groups (D’Amico’s) Low 39.7%
  Intermediate 52.0%
  High 8.3%
ADT   14.2%
SBRT Dose 36.25 Gy 88.2%
  35 Gy 11.8%